FibroGen Inc (NAS:FGEN)
$ 1.24 0.05 (4.2%) Market Cap: 123.35 Mil Enterprise Value: 90.73 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 56/100

Q2 2019 FibroGen Inc Earnings Call Transcript

Aug 08, 2019 / 09:00PM GMT
Release Date Price: $46.5 (+2.88%)
Operator

Welcome to the FibroGen's Second Quarter 2019 Financial Results Conference Call. My name is Adrianne, and I'll be your operator for today's call. (Operator Instructions) Please note this conference is being recorded.

I'll now turn the call over to Karen Bergman. Karen Bergman, you may begin.

Karen L. Bergman
FibroGen, Inc. - VP of IR & Corporate Communications

Thank you, Adrianne. Good afternoon, everyone. And thank you for joining our call. Today, we are reporting financial results and corporate update for the second quarter of 2019. Joining me today on the call are Mr. Tom Neff, Chairman and Chief Executive Officer; Dr. Peony Yu, Chief Medical Officer; Ms. Chris Chung, Senior Vice President of China Operations and Managing Director, FibroGen China; Dr. Elias Kouchakji, Senior Vice President, Clinical Development, Drug Safety and Pharmacovigilance; and Mr. Pat Cotroneo, Chief Financial Officer. Following our prepared remarks, Tom will discuss upcoming milestones and we will open the call to Q&A.

During this call, we may make forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot